Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Onkologie|July 7, 2001
Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemiaM Jarosová, K Jedlicková, M Holzerová, et al.
Neoplasma|June 25, 2013
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert)P Jindra, J Muzik, K Indrak, et al.
Vnitrni Lekarstvi|January 1, 1997
[Interferon-alpha in the treatment of patients with chronic myeloid leukemia]E Faber, M Jarosová, V Divoký, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia]E Matejková, D Ocadlíková, J Smejkalová, et al.
Vnitrni Lekarstvi|July 28, 1999
[Mantle cell lymphoma as a diagnostic and therapeutic problem]T Papajík, L Raida, E Faber, et al.
Vnitrni Lekarstvi|November 6, 2001
[Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000]M Jarosová, K Indrák, M Holzerová, et al.
Neoplasma|January 8, 2015
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experiencT Szotkowski, E Faber, J Hubacek, et al.
Leukemia & Lymphoma|June 30, 2004
High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridizationM Jarosová, T Papajík, M Holzerová, et al.
Neoplasma|July 30, 2016
The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective studyV Valkova, J Jircikova, M Trnkova, et al.
Neoplasma|August 18, 2015
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression could be an effective approach to patients with acute lymphoblastic leukemiaL Raida, Z Rusinakova, R Szotkowska, et al.
Pageof 4